Dr Kong explains why BPC157 is harder to obtain, noting bans from the World AntiDoping Agency and tighter FDA control, and raises two main worries: contaminated products from "unregulated research chemical websites" and a theoretical cancer risk because the same bloodvessel growth that heals tissue might also help tumours grow
It is the result of fixed biological differences in body composition, enzyme activity, and the mathematical constants used in alcohol pharmacokinetics
Unlike benzodiazepines, it achieves its anxiolytic effect without causing cognitive impairment, amnesia, or dependency
5 mg vial + 2 mL BAC water: Concentration = 2,500 mcg/mL 250 mcg dose = 10 units (0.1 mL) on a 100-unit insulin syringe 500 mcg dose = 20 units (0.2 mL) on a 100-unit insulin syringe Doses per vial: 20 doses at 250 mcg, or 10 doses at 500 mcg Supplies Needed (8-Week Cycle at 250 mcg/day) 3 vials BPC-157 (5 mg each) provides 60 doses, covers 56 days with margin 3 vials bacteriostatic water (30 mL each) 60 insulin syringes (2931 gauge, 100-unit) Alcohol prep pads Administration Injection Technique BPC-157 goes subcutaneous (SubQ)
Related dosage protocols and research Use the available links to move between research context, dosage pages or comparisons, and supporting guides
Adiponectin, but Not TGF-1, CTGF, IL-6 or TNF-, may be a potential anti-inflammation and anti-fibrosis factor in keloid